CNTA

Centessa Pharmaceuticals
CNTA

Overview Fund Activity

117 hedge funds and large institutions have $1.62B invested in Centessa Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 45 increasing their positions, 34 reducing their positions, and 30 closing their positions.

Holders
117
Holders Change
-12
Holders Change %
-9.3%
% of All Funds
1.57%
Holding in Top 10
10
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-28.57%
% of All Funds
0.13%
New
19
Increased
45
Reduced
34
Closed
30
Calls
$6.01M
Puts
$1.12M
Net Calls
+$4.9M
Net Calls Change
+$14.3M

Top Buyers

1
RI
1
RTW Investments
New York
$20.1M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$110M
3
Balyasny Asset Management
3
Balyasny Asset Management
Illinois
$16.1M
4
Millennium Management
4
Millennium Management
New York
$21.8M
5
PCH
5
Polar Capital Holdings
United Kingdom
$13.1M

Top Sellers

1
Holocene Advisors
1
Holocene Advisors
New York
$0
2
T. Rowe Price Investment Management
2
T. Rowe Price Investment Management
Maryland
$6K
3
PA
3
Perceptive Advisors
New York
$15.1M
4
BBA
4
Baker Bros. Advisors
New York
$0
5
Morgan Stanley
5
Morgan Stanley
New York
$23.6M
Name Market Value Shares Shares
Change 		Shares
Change %
PCH
26
Polar Capital Holdings
United Kingdom
$13.1M 1,000,000 +1,000,000 New
AAA
27
Affinity Asset Advisors
New York
$11.8M 900,162 -646,500 -42%
5VM
28
5AM Venture Management
California
$10.9M 830,945 – –
SVCM
29
Saturn V Capital Management
Texas
$10.4M 793,327 +344,635 +77%
TWM
30
Tanager Wealth Management
United Kingdom
$7.86M 598,044 -98,052 -14%
Ensign Peak Advisors
31
Ensign Peak Advisors
Utah
$7.36M 559,744 +121,611 +28%
Goldman Sachs
32
Goldman Sachs
New York
$7.35M 559,283 +157,519 +39%
NCM
33
Nantahala Capital Management
Connecticut
$7.29M 554,803 – –
TD Asset Management
34
TD Asset Management
Ontario, Canada
$7.27M 553,292 -34,830 -6%
DCM
35
Driehaus Capital Management
Illinois
$6.71M 510,779 -584,754 -53%
DTC
36
Deep Track Capital
Connecticut
$6.57M 500,000 +500,000 New
JPMorgan Chase & Co
37
JPMorgan Chase & Co
New York
$5.63M 428,434 +260,702 +155%
Capital World Investors
38
Capital World Investors
California
$5.48M 416,823 +416,823 New
WP
39
Woodline Partners
California
$5.26M 400,278 – –
AC
40
Armistice Capital
New York
$5.26M 400,000 -68,000 -15%
Renaissance Technologies
41
Renaissance Technologies
New York
$5.06M 384,900 +206,900 +116%
BlackRock
42
BlackRock
New York
$5.01M 381,125 -18,841 -5%
CS
43
Candriam SCA
Luxembourg
$4.57M 347,599 +347,599 New
PHS
44
PFM Health Sciences
California
$4.53M 344,972 -225,574 -40%
Marshall Wace
45
Marshall Wace
United Kingdom
$4.51M 343,318 +207,291 +152%
BOCH
46
Blue Owl Capital Holdings
New York
$4.34M 330,600 +15,600 +5%
Manulife (Manufacturers Life Insurance)
47
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4.17M 317,574 +14,928 +5%
Qube Research & Technologies (QRT)
48
Qube Research & Technologies (QRT)
United Kingdom
$4.05M 307,880 +278,446 +946%
ACM
49
ADAR1 Capital Management
Texas
$3.9M 296,766 +80,600 +37%
ABG
50
Ally Bridge Group
New York
$3.86M 293,986 +50,900 +21%
1
2
3 4 5